ホーム
AXYNTIS Group logo
AXYNTIS Group

会社概要

  • 正式社名: AXYNTIS Group
  • 登録国: France
  • 住所: 45 rue de Pommard, 75012, Paris
説明:

Axyntis Group, founded in 2007, is France’s leading independent multi-site player in fine chemicals with a €90 million annual turnover. Axyntis has become a key producer of APIs in France through acquisitions & partnerships. It has two divisions (dyes and fine chemicals) and places a strong focus on diversification and innovation. It operates 3 cGMP sites in France, of which 2 are FDA-inspected. It provides CDMO services to its partners for their API or advanced intermediate projects, from early-stage development to the commercial phase, including preparative chromatography (Kyrapharm subsidiary). It also commercializes proprietary APIs.

事業活動

受託・アウトソーシングサービス

サービスプロバイダー

薬事・市場調査サービス

サービスプロバイダー

試験・分析サービス

サービスプロバイダー

当社の製品・サービス

Sell · Active Pharmaceutical Ingredients (APIs)
Glibenclamide - AXYNTIS Group
Sell · Active Pharmaceutical Ingredients (APIs)
Ethionamide - AXYNTIS Group
Sell · Active Pharmaceutical Ingredients (APIs)
Imiquimod - AXYNTIS Group
Sell · Active Pharmaceutical Ingredients (APIs)
Fenofibrate - AXYNTIS Group
Sell · Active Pharmaceutical Ingredients (APIs)
Thiothixene - AXYNTIS Group
Sell · Active Pharmaceutical Ingredients (APIs)
Clioquinol - AXYNTIS Group
Sell · Active Pharmaceutical Ingredients (APIs)
Disulfiram - AXYNTIS Group
Sell · Active Pharmaceutical Ingredients (APIs)
Toltrazuril - AXYNTIS Group
Sell · Active Pharmaceutical Ingredients (APIs)
Ornidazole - AXYNTIS Group
Sell · Active Pharmaceutical Ingredients (APIs)
Metopimazine - AXYNTIS Group
Sell · Active Pharmaceutical Ingredients (APIs)
Loxapine Succinate
Sell · Active Pharmaceutical Ingredients (APIs)
Amoxapine
Sell · Active Pharmaceutical Ingredients (APIs)
Loxapine

認証

CEP証明書

FDA

WHO-GMP認証

DMF

フィルター:
並べ替え:

    コメントはありません。